Standard Chem & Pharm Co Ltd Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Standard Chem & Pharm Co Ltd - Alpha Spread

Standard Chem & Pharm Co Ltd
TWSE:1720

Watchlist Manager
Standard Chem & Pharm Co Ltd Logo
Standard Chem & Pharm Co Ltd
TWSE:1720
Watchlist
Price: 65.1 TWD 0.46% Market Closed
Market Cap: 11.6B TWD
Have any thoughts about
Standard Chem & Pharm Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Standard Chem & Pharm Co Ltd

There are no price targets for Standard Chem & Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Standard Chem & Pharm Co Ltd Competitors:
Price Targets
KOTRA
Kotra Industries Bhd
5% Upside
4536
Santen Pharmaceutical Co Ltd
12% Upside
AGY
Allergy Therapeutics PLC
179% Upside
ALIM
Alimera Sciences Inc
4% Upside
NOVN
Novartis AG
7% Upside
300723
Yipinhong Pharmaceutical Co Ltd
164% Upside
SUPRIYA
Supriya Lifescience Ltd
13% Downside

Revenue
Forecast

Revenue Estimate
Standard Chem & Pharm Co Ltd

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's revenue is 8%. The projected CAGR for the next 1 year is 11%.

8%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Standard Chem & Pharm Co Ltd

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's operating income is 16%. The projected CAGR for the next 1 year is 14%.

16%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Standard Chem & Pharm Co Ltd

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's net income is 12%. The projected CAGR for the next 1 year is 9%.

12%
Past Growth
9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Standard Chem & Pharm Co Ltd's stock price target?
Not Available

Standard Chem & Pharm Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Standard Chem & Pharm Co Ltd's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's revenue is 8%. The projected CAGR for the next 1 year is 11%.

What is Standard Chem & Pharm Co Ltd's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's operating income is 16%. The projected CAGR for the next 1 year is 14%.

What is Standard Chem & Pharm Co Ltd's Net Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Standard Chem & Pharm Co Ltd's net income is 12%. The projected CAGR for the next 1 year is 9%.

Back to Top